Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amedisys Inc (AMED)
NASDAQ:AMED
Amedisys (AMED) Stock Price & Analysis
432 Followers
AMED Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$73.10 - $96.44
Previous Close$90.4
Volume384.90K
Average Volume (3M)283.68K
Market Cap
$2.95B
Enterprise Value$3.37B
Total Cash (Recent Filing)$126.50M
Total Debt (Recent Filing)$487.23M
Price to Earnings (P/E)-289.0
Beta0.39
Next Earnings
May 01, 2024EPS Estimate
$1.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding32,667,631
10 Day Avg. Volume235,783
30 Day Avg. Volume283,681
Standard Deviation0.11
R-Squared0.16
Alpha-0.00823
Financial Highlights & Ratios
Price to Book (P/B)-10.51
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)12.20
P/FCF Ratio11.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.90
Enterprise Value/Gross Profit-2.70
Enterprise Value/Ebitda25.95
Forecast
1Y Price Target
$100.75Price Target Upside11.45% Upside
Rating ConsensusHold
Number of Analyst Covering4
Amedisys News
PremiumCompany Announcements
Amedisys Acquisition Faces Intense Regulatory Review
PremiumCompany Announcements
Amedisys Inc Shares Q4 Insights with Investors
PremiumPre-Earnings
Is AMED a Buy, Before Earnings?
Bulls Say, Bears Say
Bulls Say
Acquisition ImpactThe acquisition by UnitedHealth Group remains a key factor in the current valuation of the company.
Cash Flow PerformanceCash flow operations exceeded estimates, and free cash flow showed a significant sequential increase as a percentage of adjusted net income.
Stock RatingAnalyst maintains a Market Perform rating, indicating steady expectations for the company's stock performance.
Bears Say
Cost PressuresInflationary corporate overhead pressures contributed to a year-to-year decrease in consolidated EBITDA.
Earnings GrowthThe company's long-term estimated EPS growth is negative, indicating potential concerns about future earnings per share.
Earnings Performance4Q23 slightly missed consensus EBITDA, with lower home health aid volume partially offsetting higher year-to-year care plan volume.
---
Ownership Overview
23.88% Insiders
39.05% Mutual Funds
23.35% Other Institutional Investors
13.72% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AMED FAQ
What was Amedisys Inc’s price range in the past 12 months?
Amedisys Inc lowest stock price was $73.10 and its highest was $96.44 in the past 12 months.
What is Amedisys Inc’s market cap?
Currently, no data Available
When is Amedisys Inc’s upcoming earnings report date?
Amedisys Inc’s upcoming earnings report date is May 01, 2024 which is in 8 days.
How were Amedisys Inc’s earnings last quarter?
Amedisys Inc released its earnings results on Feb 21, 2024. The company reported $0.94 earnings per share for the quarter, missing the consensus estimate of $1.032 by -$0.092.
Is Amedisys Inc overvalued?
According to Wall Street analysts Amedisys Inc’s price is currently Undervalued.
Does Amedisys Inc pay dividends?
Amedisys Inc does not currently pay dividends.
What is Amedisys Inc’s EPS estimate?
Amedisys Inc’s EPS estimate is $1.02.
How many shares outstanding does Amedisys Inc have?
Amedisys Inc has 32,667,630 shares outstanding.
What happened to Amedisys Inc’s price movement after its last earnings report?
Amedisys Inc reported an EPS of $0.94 in its last earnings report, missing expectations of $1.032. Following the earnings report the stock price went up 0.951%.
Which hedge fund is a major shareholder of Amedisys Inc?
Among the largest hedge funds holding Amedisys Inc’s share is Woodline Partners LP. It holds Amedisys Inc’s shares valued at 42M.
---
Amedisys Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$100.75 (11.45% Upside)
$100.75 (11.45% Upside)
Hedge Fund Trend
Increased
By 56.2K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
18.00%
12-Months-Change
Fundamentals
Return on Equity
-0.92%
Trailing 12-Months
Asset Growth
4.25%
Trailing 12-Months
Company Description
Amedisys Inc
Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, and Personal Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The company was founded by William F. Borne in 1982 and is headquartered in Baton Rouge, LA.
---
AMED Company Deck
---
AMED Earnings Call
Q4 2023
0:00 / 0:00
---
AMED Stock 12 Months Forecast
Average Price Target
$100.75
▲(11.45% Upside)
Technical Analysis
Best Analysts Covering AMED
1 Year
1 Year Success Rate
2/8 ratings generated profit
1 Year Average Return
-12.49%
reiterated a buy rating 29 days ago
Copying Ben Hendrix's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -12.49% per trade.
---